Guidant Receives Amended Offer from Boston Scientific Guidant's Board to Evaluate Offer
17 Janvier 2006 - 3:33PM
Business Wire
Guidant Corporation (NYSE:GDT) acknowledges receipt today, January
17, 2006, of an amended offer from Boston Scientific Corporation to
acquire Guidant for $80 per Guidant share made up of a combination
of $42.00 in cash and $38.00 in Boston Scientific common stock,
subject to a collar. The value of the Boston Scientific amended
offer is approximately $27.2 billion. Guidant's recently amended
merger agreement with Johnson & Johnson provides that each
share of Guidant common stock would be exchanged for $40.52 in cash
and .493 shares of Johnson & Johnson common stock. As of close
of business on January 13, 2006, the Johnson & Johnson proposal
was valued at $71.00 per Guidant share. Guidant's Board of
Directors will evaluate all aspects of the amended offer from
Boston Scientific, with the assistance of its investment bankers,
JPMorgan Chase & Company and Morgan Stanley together with its
outside counsel, Skadden, Arps, Slate, Meagher & Flom LLP.
Guidant Corporation pioneers lifesaving technology, giving an
opportunity for better life today to millions of cardiac and
vascular patients worldwide. The company develops, manufactures and
markets a broad array of products and services that enable less
invasive care for some of life's most threatening medical
conditions. For more information, visit www.guidant.com. Guidant
Corporation and Johnson & Johnson have filed with the
Securities and Exchange Commission (SEC) a definitive proxy
statement/prospectus and other documents regarding the proposed
merger between Guidant and Johnson & Johnson. Investors are
urged to read the definitive proxy statement/prospectus and any
other relevant documents filed with the SEC because they contain
important information. The proxy statement/prospectus and other
documents filed by Johnson & Johnson and Guidant with the SEC
are available free of charge at the SEC's website, www.sec.gov, or
by directing a request to Johnson & Johnson, One Johnson &
Johnson Plaza, New Brunswick, NJ 08933, Attention: Investor
Relations; or by directing a request to Guidant Corporation, 111
Monument Circle, #2900, Indianapolis, IN 46204-5129, Attention:
Investor Relations. Guidant Corporation, its directors, and certain
of its executive officers may be considered participants in the
solicitation of proxies in connection with the proposed
transactions. Information about the directors and executive
officers of Guidant and their ownership of Guidant stock is set
forth in Guidant's most recent filing on Form 10-K. Investors may
obtain additional information regarding the interests of such
participants by reading the definitive proxy statement/prospectus.
Guidant (NYSE:GDT)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Guidant (NYSE:GDT)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024
Real-Time news about Guidant Corp (New York Stock Exchange): 0 recent articles
Plus d'articles sur Guidant Corporation